CancerNCT02376894
An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients
An observational study of Cancer, run by Taiwan Cancer Palliative Medicine at 1 site in Taiwan.
Trial summary
The aim of this study is to examine the prevalence, severity, impacts and managements of CRF among Taiwanese cancer patients. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Cancer
- How many people
- 1,211 participants
- Where
- 1 siteTaiwan
- Study dates
- Feb 2015to May 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: cancer patient
Who may be able to join
- (1) Patients who signed the informed consent form
- (2) The age of eligible patients should be > 20 years old.
- (3) Inpatients or outpatients who have been given a diagnosis of cancer
- (4) Able to communicate verbally and completely fill out the questionnaires
Who cannot join
- Patients who have been given a diagnosis of cognitive impairment are unable to complete the questionnaires
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study is to examine the prevalence, severity, impacts and managements of CRF among Taiwanese cancer patients.
Read the detailed description
The cross-sectional survey is conducted at oncology inpatients unit and outpatients clinics of hospitals in Taiwan. Furthermore, the results will elucidate not only the epidemiology of CRF in Taiwan, but will supply physicians with more understanding about CRF, and help them to enhance the quality on cancer care to being perfected in the future.
- Conditions
- Cancer
- Medical subject headings
- Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Cancer-related fatigue evaluation
ICD-10 Fatigue Criteria,Brief Fatigue Inventory-Taiwan Form
Measured: 30 minuts
Symptoms and Quality of Life Assessments
FACT-G7
Measured: 15 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Mar 2015 (estimated)
- Study startFeb 2015
- Primary completionMay 2015
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,211 participants (actual)
Sponsor and investigators
- Lead sponsor
- Taiwan Cancer Palliative Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- National Taiwan University Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tri-Service General Hospital (TSGH), Changhua Christian Hospital, National Cheng-Kung University Hospital, Chung Shan Medical University, Kaohsiung Veterans General Hospital., Taipei Veterans General Hospital, Taiwan, Taipei Medical University Hospital, Taipei Medical University Shuang Ho Hospital, Taipei Medical University WanFang Hospital, China Medical University Hospital, Mackay Memorial Hospital, Far Eastern Memorial Hospital, Chang Gung Memorial Hospital, Chiayi Christian Hospital, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung Tzu Chi Hospital, Chi Mei Medical Hospital
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02376894
- Sponsor's protocol ID
- CRF-TSCPM01
- Status last verified
- Jan 2018
- First submitted
- 25 Feb 2015
- Last updated
- 10 Jan 2018
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Epidemiological Survey of Cancer-related Fatigue Among Taiwanese Cancer Patients
- ClinicalTrials.gov ID
- NCT02376894
- Acronym / sponsor ID
- CRF-TSCPM01
- Conditions
- Cancer
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,211 participants (actual)
- Lead sponsor
- Taiwan Cancer Palliative MedicineUniversity, hospital or other
- Collaborators
- National Taiwan University Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Tri-Service General Hospital (TSGH), Changhua Christian Hospital, National Cheng-Kung University Hospital, Chung Shan Medical University, Kaohsiung Veterans General Hospital., Taipei Veterans General Hospital, Taiwan, Taipei Medical University Hospital, Taipei Medical University Shuang Ho Hospital, Taipei Medical University WanFang Hospital, China Medical University Hospital, Mackay Memorial Hospital, Far Eastern Memorial Hospital, Chang Gung Memorial Hospital, Chiayi Christian Hospital, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung Tzu Chi Hospital, Chi Mei Medical Hospital
- Study start
- Feb 2015 (actual)
- Primary completion
- May 2015 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 3 Mar 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to examine the prevalence, severity, impacts and managements of CRF among Taiwanese cancer patients.
Detailed description
The cross-sectional survey is conducted at oncology inpatients unit and outpatients clinics of hospitals in Taiwan. Furthermore, the results will elucidate not only the epidemiology of CRF in Taiwan, but will supply physicians with more understanding about CRF, and help them to enhance the quality on cancer care to being perfected in the future.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- cancer patient
Key inclusion criteria (4 listed)
- (1) Patients who signed the informed consent form
- (2) The age of eligible patients should be > 20 years old.
- (3) Inpatients or outpatients who have been given a diagnosis of cancer
- (4) Able to communicate verbally and completely fill out the questionnaires
Key exclusion criteria (1 listed)
- Patients who have been given a diagnosis of cognitive impairment are unable to complete the questionnaires
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Cancer-related fatigue evaluation
Time frame: 30 minuts
ICD-10 Fatigue Criteria,Brief Fatigue Inventory-Taiwan Form
Symptoms and Quality of Life Assessments
Time frame: 15 minutes
FACT-G7
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jan 2018.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Taiwan Cancer Palliative Medicine at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cancer-related fatigue evaluation (time frame: 30 minuts). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2018.